Rs4430796

From SNPedia

Jump to: navigation, search
is asnp
is mentioned by
dbSNPrs4430796
hapmaprs4430796
hgdprs4430796
ensemblrs4430796
gopubmedrs4430796
scholarrs4430796
googlers4430796
pharmgkbrs4430796
hgvbaseg2prs4430796
medrefsnprs4430796
23andMers4430796
SNP Nexus

GeneTCF2
Chromosome17
Orientationplus
Position33172152
GenotypeEffect
rs4430796(A;A)1.38x increased risk for prostate cancer
rs4430796(A;G)normal risk
rs4430796(G;G)normal risk


Genotypes Magnitude Summary
Rs4430796(A;A) 2.12.1 1.38x increased risk for prostate cancer
Rs4430796(A;G) 00 normal risk
Rs4430796(G;G) 00 normal risk

rs4430796 is a SNP in the TCF2 gene on chromosome 17q12, associated with increased risk for prostate cancer in several studies.

In a study of over 3,600 Caucasians with prostate cancer, rs4430796 is one of five SNPs used (with family history as a sixth factor) to cumulatively predict overall risk. On its own, the rs4430796(A;A) risk genotype - in dbSNP orientation, not as published - yields an odds ratio for developing prostate cancer of 1.38 (CI: 1.21-1.57, p=1.6x10e-6) and may account for 10.2% of population attributable risk.10.1056/NEJMoa075819

article linking to Prostate cancer and type-2 diabetes

[PMID 18701471] 403 non-Hispanic white families were studied, totaling 1,015 men, to reach the conclusion that the rs4430796(A) allele is associated with increased prostate cancer risk; the odds ratio was 1.40 (CI: 1.09-1.81) under an additive genetic model. Notably, rs4430796(A) was significantly associated with prostate cancer among men diagnosed at an early (<50 years) but not later age (P = 0.006 versus P = 0.118). The increased risk associated with rs4430796 and the closely linked rs7501939 is approximately doubled in individuals hereditarily predisposed to develop early-onset prostate cancer.

[PMID 19998368] rs4430796 identified as one of three HNF1B gene SNPs associated with decreased risk for prostate cancer in two large prospective studies

? (A;A) (A;G) (G;G)
GWAS
SNP rs4430796
PubMedID [PMID 17603485]
Condition Prostate cancer
Gene TCF2
Risk Allele A
pValue 1.00E-011
OR 1.22
95% CI 1.15-1.30


GWAS snp
PMID [PMID 18264096]
Trait Prostate cancer
Title Multiple loci identified in a genome-wide association study of prostate cancer
Risk Allele A
P-val 1.0000000000000001E-9
Odds Ratio 1.18 [1.04-1.32]
Related to PROSTATE CANCER according to omim 176807. See also


Related to PROSTATE CANCER, HEREDITARY, 11; HPC11 according to omim 611955. See also


Related to DIABETES MELLITUS, NONINSULIN-DEPENDENT; NIDDM according to omim 125853. See also
GWAS snp
PMID [PMID 19767754]
Trait Prostate cancer
Title Genome-wide association and replication studies identify four variants associated with prostate cancer susceptibility
Risk Allele A
P-val 0.000008
Odds Ratio 1.19 [1.10-1.28]

[PMID 19726753] Replication of prostate cancer risk loci in a Japanese case-control association study

PharmGKBPA162355653
Name
AnnotationIn a fine-mapping study in the HNF1B gene at 17q12 this variant was associated with prostate cancer risk.
GeneHNF1B
Featue
EvidencePubMed ID:18758462
Drugs
DiseasesProstatic Neoplasms
Curation LevelCurated


[PMID 20203524] Genetic Susceptibility to Type 2 Diabetes Is Associated with Reduced Prostate Cancer Risk